HK:9926 Stock Latest News
PremiumCompany AnnouncementsAkeso, Inc. Aims to Raise HK$1.94 Billion in Share Placement Akeso, Inc.’s New Cholesterol Drug Approved in China Akeso’s Breakthrough Drug Wins Approval for Gastric Cancer PremiumCompany AnnouncementsAkeso’s Cancer Drug Ivonescimab Shows Promising Trial Results Akeso, Inc. Appoints New CFO, Dr. Bing Wang Akeso, Inc. Reveals Board of Directors Structure PremiumCompany AnnouncementsAkeso Broadens Ivonescimab Agreement With Summit Akeso’s Ivonescimab Outperforms in Clinical Trial Akeso, Inc.’s New Cancer Drug Wins China Approval